Key words: transplantation, rejection, costimulatory molecules Background. CTLA-4/CD28-B7 and CD40-CD40L interactions constitute two key costimulatory pathways in lymphocyte signalling during experimental allograft rejection. Studies on the expression of these
Introduction
molecules in human transplant rejection are still lacking. Methods. The immunohistochemical study was per-The identification of surface receptors responsible for formed on renal biopsies obtained for various clinical lymphocyte costimulatory signals has uncovered new complications from 25 renal transplant patients. critical mechanisms which are involved in graft rejecExpression of B7-1 and B7-2 and their counter-tion. Indeed, it has been shown that the interaction receptor CTLA-4, and of CD40 and its counter-between the B7-1 and B7-2 receptors, expressed on receptor CD40L was examined.
the surface of antigen-presenting cells (APC ), and Results. In acute rejection a focal intense infiltration their counter-receptors CD28 and CTLA-4, present of B7-1+ and B7-2+ cells (mainly CD20− CD14+) on T lymphocytes, triggers a crucial costimulatory and of CTLA-4+ T lymphocytes (mainly CD8+) was signal for T cells that acts in concert with the interpresent. In contrast, CD40 and CD40L were rarely action between MHC-II and TCR-CD3 (principal expressed. Accumulations of T lymphocytes were stimulatory signal ) [1] . In the absence of costimulatory found in the interstitium in the same area containing signals, the T lymphocyte is not activated and is B7-1+ and B7-2+ cells. The scattered CD40L+ cells rendered anergic, thus favouring the induction of found in the T-cell infiltrate exhibited the CD4+ immunological tolerance [1] . The demonstration in phenotype.
several experimental models that blocking this signal In chronic rejection only a few B7-1+, B7-2+ or prevents graft rejection [2] [3] [4] , and in some cases CTLA-4+ cells were detectable. In contrast, several induces tolerance [2] , suggests a new therapeutical strategy which takes advantage of technologies of CD40L+CD4+ cells were present both in the interstitmolecular engineering. T-lymphocyte stimulation by ium and in glomeruli. Moreover, an intense expression B7-1 and B7-2 and by antigen recognition induces of CD40 on the endothelium was observed. In patients the expression of a 39 kDa surface glycoprotein, called with cyclosporin nephrotoxicity cells positive for CD40Ligand (CD40L) [5] , which binds to CD40 pre-B7-1, B7-2, CTLA-4, CD40, or CD40L were absent.
sent The aim of this study was to evaluate the expression with epifluorescence optics and appropriate filters. Fifteen to of the inducible B7-1, B7-2, CTLA-4 and CD40L twenty randomly selected microscopic fields of three nonin the biopsy tissue of patients receiving renal consecutive sections were examined and scored at ×400 transplantation.
magnification (Plan-Neofluoral 40/0.9 glycerol immersion objective, Zeiss) by two independent observers. Doublestaining was performed by incubating sections with a directly
Subjects and methods
PE-conjugated monoclonal antibody anti-CD4, CD8, CD20, or CD14, as third step.
Patients
The intensity of staining was graded on a scale from 0 to +4 (0, absent; +1, weak; +2, moderate; +3, marked; Twenty-five recipients of cadaver kidney transplants (16 +4, bright). males, 9 female, mean age 43±9.8 years) entered this study. The underlying renal disease was chronic glomerulonephritis in three, polycystic kidney disease in two, Berger's disease in Results one, Schö nlein-Henoch nephropathy in one, nephroangiosclerosis in one, nephrolithiasis in one, reflux nephropathy Ten control human renal tissues obtained from kidney in one, membranoproliferative glomerulonephritis in three, nephrectomized for polar renal carcinoma or trauma, glomerulosclerosis in two, chronic pyelonephritis in two, post-streptococcal acute glomerulonephritis in one, and did not express any of the costimulatory molecules undefined in seven. Immunosuppression was maintained in involved in this study, with the exception of CD40 11 patients with steroids and azathioprine and in 14 patients which was weakly expressed on glomerular and perituwith a protocol including also cyclosporin A (CsA). bular capillary endothelial cells. In contrast, several A retrospective study of costimulatory molecules was cells positive for CTLA-4 with a typical intracytoperformed on selected patients with biopsy-proven graft plasmic pattern ( Figure 1A) , and for B7-1 and B7-2 complications. Patients were categorized on the basis of were detectable in renal biopsies of patients with acute 2) on cells infiltrating the tubular interstitial space. In recipients with chronic allograft nephropathy consistent with chronic rejection (7 patients); (3) recipients with CsA nephro-contrast, absence of staining was observed in the toxicity (4 patients). The latter was defined as decreased glomerular tufts. Double staining immunofluorescence renal function or increased serum levels of creatinine followed indicated that B7-1+ cells were also CD14+ and by a favourable response to CsA dosage reduction in the CD20−, suggesting that the expression of B7-1 was presence of a suggestive percutaneous renal biopsy, which mainly confined to monocyte/macrophages or dendritic excluded acute rejection, chronic allograft nephropathy, or cells rather than to B cells. Double staining for B7-1 acute tubular necrosis [11].
or B7-2 and CD8 or CD4 was never observed. Moreover, no staining of renal resident cells was Reagents and immunofluorescence microscopy evident. B7-2 expression followed the same pattern of B7-1 ( Figure 1D ) and was confined mainly to CD Fluorescein-(FITC )-conjugated mouse anti-human CD4, 14+ cells. Analysis of serial sections suggests that the (DP+DQ+DR) antigen was from Novocastra (Newcastle, UK ). Goat anti-human CTLA-4, B7-1, B7-2, and rabbit frequently coexpressed also B7-1, but with a lower anti-human CD40L and CD40 (Santa Cruz Biotechnology, intensity (+1/+2). MHC class-II antigens were Santa Cruz, CA) reacted to an epitope mapping at the expressed not only on cells infiltrating the interstitium carboxyl terminus and corresponding to amino acids 205-223 but also on vascular endothelial and tubular cells (CTLA-4), 269-288 (B7-1), 302-320 (B7-2), 239-258 ( Figure 1E ). Likewise, CTLA-4 was detectable on (CD40L) and 258-277 (CD40). Preincubation of polyclonal the lymphocyte infiltrate in the tubular interstitial antibodies with corresponding peptide antigen resulted in compartment ( Figure 1A ). The lymphocyte infilabsence of staining in tissue sections expressing the receptors. trate contained both CD4+ and CD8+ lymphocytes ( Figure 3B ) were detectable, whereas several CD40L+ Cryostat-cut 5-mm tissue sections were mounted onto slides cells were present both in the interstitium around and stained with the primary antibody (2 mg/ml ) for 1 h at vessels ( Figure 3C ) and in glomeruli ( Figure 3D ). The RT, washed with PBS and then incubated with FITC-CD40L expression was particularly bright (+3). Of conjugated second-step antibody. After washing several times CD40L+ cells, 75-80% were CD4+, whereas the in PBS, the sections, mounted in a solution of PBS-glycerol 151 containing 1% DMSO as anti-fading agent, were exam-remaining cells were CD8+. In chronic rejection an intense and diffuse staining for CD40 was observed on allograft recipients undergoing acute or chronic rejecperitubular capillaries and on glomerular endothelium, tion. In acute rejection a focal intense infiltration of whereas CD40 was only minimally and focally B7-1+ and B7-2+ cells and of CTLA-4+ T lymphoexpressed on glomerular and peritubular capillary cytes was present. In contrast, CD40 and CD40L were endothelial cells in acute rejection (Figure 4) . infrequently expressed. In chronic rejection only few In patients with CsA nephrotoxicity cells positive B7-1+, B7-2+ or CTLA-4+ cells were detectable, for B7-1, B7-2, CTLA-4, CD40L or CD40 were whereas several CD40L+CD4+ cells were present both virtually absent ( Figure 2C ).
in the interstitium and in glomeruli. Moreover, intense expression of CD40 on the endothelium was observed.
In patients with cyclosporin nephrotoxicity, cells
Discussion
positive for B7-1, B7-2, CTLA-4, CD40 or CD40L were absent. Several experimental studies identified the interThe present study demonstrates a differential expression of costimulatory molecules in renal biopsies of action between CD28/CTLA-4 on T cells with their The receptor-ligand pair composed of the B-cellassociated receptor CD40 and its T-cell ligand CD40L has been shown to play a key role in the regulation of T-cell-dependent antibody production [17] . The physiological importance of the CD40-CD40L interaction was discovered through the elucidation of the underlying defect in a severe form of human immunodeficiency known as the hyper-IgM syndrome [10] . Beside its role in T-B-cell interaction, it now appears evident that this receptor pair is deeply involved in the basic mechanisms of T-cell activation and cell-mediated immune response. Experimental studies on allograft rejection recently showed that anti-CD40L therapy induced prolonged survival of murine cardiac allograft in both naive and sensitized hosts [18] . In addition, in combination with B7 blockade or with pretreatment with donor APC, CD40L blockade seems to evoke immunological tolerance to skin and cardiac allograft [13] , and islet allograft [19] respectively. Combined blockade of the CD40-CD40L and CD28/CTLA4-B7-1/B7-2 pathways is also protective versus chronic vascular rejection of primarily vascularized allograft [13] .
In the present study we provide evidence for the local expression of inducible costimulatory molecules such as B7-1+ and B7-2+ and of CTLA-4+ in acute rejection. The results obtained by double staining immunofluorescence indicated that B7-1+ and B7-2+ cells were monocyte/macrophages or dendritic cells rather than B or T cells. In fact they were positive for CD14, which may be expressed both by monocyte/ macrophages and dendritic cells, but negative for with a pattern of staining consistent with the previously reported intracytoplasmatic presence of this molecule [1] . In acute rejection CTLA-4+ T-cells were observed ligands B7-1 and B7-2 on APC as the primary costimulatory pathway involved in specific T-cell activation in the areas of B7-1+/B7-2+ cell infiltration, suggesting a cell-to-cell interaction through the during allograft and xenograft rejection [2-4]. Interestingly, CTLA-4 is neo-expressed mainly on CD28/CTLA-4 receptors and the B7-1/B7-2 counterreceptors. The expression of CTLA-4, which at variactivated CD8+ [1] and its role seems to counteract T-cell activation by competing 10 time more efficiently ance of CD28 is inducible [1], suggests activation of CD28/CTLA4-B7-l/B7-2 pathway within the graft. In with CD28 for the binding to B7-1 and B7-2 [1]. It has been suggested that CTLA-4 transduces a negative particular, this costimulatory pathway is activated in CD8+ lymphocytes which are known to play an signal involved in the downregulation of immune response initiated by the CD28 engagement [1] . Its effector role in acute rejection [20, 21] . These results are consistent with the demonstration that CTLA-4 privileged binding affinity to B7s in respect to CD28 was exploited by researchers for developing recombin-gene expression is increased in acute rejection [22] . It is well established that CD4+ T lymphocytes initiate ant reagents able to therapeutically interfere in this pathway. Indeed, a soluble CTLA-4Ig fusion protein acute rejection [23, 24] . Detection of CD4+ CD40L+ cells may reflect specific activation of T-helper lymphocomposed of the extracellular portion of CTLA-4 and an immunoglobulin IgG constant region was shown cytes. However, the results of the present studies D, ×250) . A, slight staining for CD40 was observed on the endothelium of glomerular (G) capillary loops and focally in the interstitium (head-arrow) of an acute rejection. B and C, intense and diffuse staining for CD40 in a glomerulus (G) and in peritubular capillaries in a patient with chronic rejection. D, negative staining of renal biopsy from a patient with CsA nephrotoxicity.
indicate 
